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Altered lipid metabolism could drive the bone marrow failure
in fanconi anaemia
Fanconi anaemia (FA) is a genetic disease caused by mutations
in at least 22 genes. The main clinical aspects are bone marrow
(BM) failure and predisposition to develop cancer, particularly
acute myeloid leukaemia (AML). Despite numerous studies,
the mechanisms responsible for BM failure in FA are not yet
well defined. DNA repair has long been considered the main
Fig 1. Evaluation of lipid metabolism in FA cells and in lymphocytes from FA patients. (A) Markers of lipid metabolism in wt, Fanconi anaemia
(FA) and FA-corr lymphoblasts, as well as in lymphocytes isolated from FA patients and relative control. In particular, the panel reports the Acetyl-
CoA concentration and the activities of 3-hydroxyacyl-CoA dehydrogenase, as markers of beta-oxidation, and b-ketoacyl-ACP reductase and Enoyl-
ACP-reductase assay, as markers of fatty acid synthesis, and the lipid content. Data are representative of five independent experiments and are
expressed as mean  SD. **indicates a significant difference for P < 001 between FA lymphoblasts or FA lymphocytes with respect to the control
samples. The presence of lipid droplets in FA lymphoblasts has been estimated by oil red staining and electron microscopy. (B) The effect of treatment
with C75 (4-methylene-2-octyl-5-oxotetra- hydrofuran-3-carboxylic acid), inhibitors of fatty acid synthesis on the activities of b-ketoacyl-ACP reduc-
tase and Enoyl-ACP-reductase in FA lymphoblasts. Moreover, the effects A922500, a specific inhibitor of triglycerides synthesis, were also evaluated on
the lipid content and the Acetyl-CoA concentration. Data are representative of five independent experiments and are expressed as mean  SD. **sig-
nificant difference (P < 001) between treated and untreated FA lymphoblasts. The enzymatic activities are expressed as mUnits/mg (mU/mg), which
correspond to the nmoles of substrate catalysed in 1 min. FANCA, Fanconi anaemia complementation group A; FANCA-corr, Fanconi anaemia com-
plementation group A-corrected; LD, lipid droplets; wt, wild type. [Colour figure can be viewed at wileyonlinelibrary.com]
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molecular hallmark of FA cells. However, in recent years, other
aberrant cellular pathways have emerged as important contrib-
utors to the pathogenesis of the disease. Among these, mito-
chondria dysfunction and oxidative stress were shown to have
a role in the deranged functioning of FA cells (Du et al, 2008).
In particular, it appears that a defect of the respiratory chain
in FA cells increases oxidative stress and that this is associated
with glucose dysmetabolism and insulin resistance, chromo-
some instability, reduced metalloproteases activity and cyto-
toxic effects of tumour necrosis factor-alpha. Recently it has
been shown that FA cells try to compensate for the mitochon-
dria impairment by enhancing the glycolysis pathway,
although this metabolic shift does not completely restore the
energetic status (Cappelli et al, 2017).
Lipid metabolism, which is mainly composed of beta-oxida-
tion and lipid synthesis according to the energetic need of the cell,
is another pathway involved in cellular energy balance. Normally,
high-energy demand enhances beta-oxidation, whereas high ATP
levels stimulate lipogenesis. However, in the case of mitochondria
dysfunction and oxidative stress, an increment of lipid metabo-
lism and lipid droplet accumulation occur which, in turn, gener-
ate an increase in oxidative stress production (Furukawa et al,
2004), in a self-sustained negative loop. Of note, about 50% of FA
patients develop lipid metabolism disorder (Giri et al, 2007).
Lipid metabolism of FA cells has not been investigated to date. In
this study we evaluated how the synthesis and beta-oxidation of
fatty acids are modulated in FA cells. The Materials and Methods
are detailed in Appendix S1.
We have previously demonstrated that FA cells preferentially
convert glucose to lactate rather than use it for the aerobic
metabolism, despite the normal activity of pyruvate dehydroge-
nase (Cappelli et al, 2017). However, when analysing the intra-
cellular concentration of Acetyl CoA (AcCoA), we have
observed that FA cells displayed a higher concentration with
respect to the control and corrected samples (Fig 1A). Given
that AcCoA is produced not only by aerobic glucose catabo-
lism, but is also formed by beta-oxidation of fatty acid, we eval-
uated the activity of 3-hydroxyacyl-CoA dehydrogenase, and
observed that FA cells displayed a lower activity compared to
controls and corrected samples (Fig 1A). This suggests that the
increased AcCoA content in FA cells is not due to the increased
fatty acid oxidation, but may be dependent on impairment of
the oxidative phosphorylation activity. In other words, the
defect in the electron transfer between complexes I and III may
determine a slowing of the Krebs cycle flux, causing AcCoA
accumulation.
However, considering that cells need to recycle CoA, to
maintain a constant availability, we have evaluated the activi-
ties of b-ketoacyl-ACP reductase and enoyl-Acyl reductase,
two enzymes involved in fatty acids synthesis. Data show that
this metabolism appeared to be higher in FA cells compared to
control and corrected samples, determining a fatty acid lipid
accumulation (Fig 1A). Normally, excess lipids are stored in
the cell as triglycerides, and then packaged into cytoplasmic
lipid droplets (LDs) to protect the cell against lipotoxicity (Lis-
tenberger et al, 2003). Red oil staining and electron
Fig 2. Correlation between lipid metabolism alteration and haematopoietic stem cells differentiation. The scheme shows the correlation between altered
lipid metabolism and haematopoietic stem cells (HSC) decline in Fanconi anaemia (FA) cells with respect to a healthy sample. In particular, the literature
reports that an increased population of adipocytes has been observed in the bone marrow of FA patients probably as a consequence of FA mesenchymal
stem cells preferentially differentiating as adipocytes, which are deleterious for HSC self-renewal (Zhou et al, 2017). AcCoA, Acetyl-CoA; FANCA, Fanconi
anaemia complementation group A; OXPHOS, oxidative phosphorylation; WT, wild type. [Colour figure can be viewed at wileyonlinelibrary.com]
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microscopy of FA lymphoblasts showed an increment in LDs
compared to FA corrected cells, confirming an excess of lipids
production in FA cells (Fig 1A).The results on enzymatic
activity and cell lipid content were confirmed in primary lym-
phocytes obtained from FA patients (Fig 1A) and in Fanc-D2
cell lines (data not shown).
We obtained further confirmation of our results using C75
(4-methylene-2-octyl-5-oxotetra- hydrofuran-3-carboxylic
acid), an inhibitor of fatty acid synthesis, and A922500, an
inhibitor of triglycerides synthesis. In particular, FA cells trea-
ted with C75 show a reduction of b-ketoacyl-ACP reductase
and enoyl-Acyl reductase (Fig 1B). Moreover, both C75 and
A922500 produced about a 30% decrease in lipid content and
an increase in AcCoA content (Fig 1B), confirming that FA
cells convert the excess of AcCoA to fatty acids, which are
accumulated in LDs.
From our results it appears evident that lipid metabolism is
altered in FA cells. Interestingly this finding suggests that the
decline in haematopoietic stem cells (HSC) could be correlated
with the alteration of this metabolic pathway (Fig 2). In this
regard, an increased population of adipocytes has been
observed in the BM of FA patients and mouse models (Pul-
liam-Leath et al, 2010), probably as a consequence of FA mes-
enchymal stem cells preferentially differentiating as adipocytes
(Zhou et al, 2017), which appear deleterious for HSC self-
renewal (Naveiras et al, 2009). Moreover, PPARG, a key regula-
tor of adipocyte differentiation and lipid synthesis, is up-regu-
lated in CD34+ cells from FA patients (Sertorio et al, 2017),
confirming the deregulation in FA cells of lipid metabolism.
Finally, our observation of reduced fatty acid beta-oxida-
tion in FA cells represents an important event in HSC
renewal, considering that the reduction of beta oxidation has
an important role in self-renewal asymmetric division of
HSC (Ito et al, 2012) and in driving HSC differentiation.
Based on these data, we conclude that the interest on bio-
chemical metabolism does not represent only a scientific
curiosity in FA cells, but that it is strongly connected with
the clinical aspects of this disease and may suggest relevant
clues in diseases prone to BM failure.
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